Forsta AP Fonden Sells 17,300 Shares of Agilent Technologies, Inc. $A

Forsta AP Fonden lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 17.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 79,600 shares of the medical research company’s stock after selling 17,300 shares during the quarter. Forsta AP Fonden’s holdings in Agilent Technologies were worth $9,394,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in A. Generation Investment Management LLP grew its position in Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock valued at $582,976,000 after purchasing an additional 824,243 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Agilent Technologies by 18.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock worth $448,748,000 after buying an additional 604,124 shares in the last quarter. Mackenzie Financial Corp boosted its stake in shares of Agilent Technologies by 141.5% during the 1st quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company’s stock worth $109,481,000 after buying an additional 548,344 shares during the last quarter. Woodline Partners LP grew its holdings in shares of Agilent Technologies by 681.6% in the 1st quarter. Woodline Partners LP now owns 522,073 shares of the medical research company’s stock valued at $61,072,000 after acquiring an additional 455,276 shares in the last quarter. Finally, Nordea Investment Management AB grew its holdings in shares of Agilent Technologies by 16.2% in the 2nd quarter. Nordea Investment Management AB now owns 3,213,748 shares of the medical research company’s stock valued at $383,143,000 after acquiring an additional 447,207 shares in the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on A. Rothschild & Co Redburn started coverage on Agilent Technologies in a report on Wednesday, October 8th. They set a “buy” rating and a $165.00 target price on the stock. Rothschild Redb raised Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. Evercore ISI raised their target price on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an “in-line” rating in a research note on Tuesday, October 7th. Finally, UBS Group upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $130.00 to $170.00 in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies has a consensus rating of “Moderate Buy” and an average target price of $149.62.

Agilent Technologies Stock Performance

Shares of NYSE A opened at $146.75 on Friday. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $41.60 billion, a P/E ratio of 34.45, a P/E/G ratio of 4.67 and a beta of 1.29. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $153.84. The stock has a 50 day moving average of $137.27 and a 200-day moving average of $123.50.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the prior year, the business earned $1.32 EPS. The firm’s revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were issued a dividend of $0.248 per share. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is presently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.